A prospective, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of SNZ TriBac, a three-strain Bacillus probiotic blend for undiagnosed gastrointestinal discomfort
2019 ◽
Vol 34
(11)
◽
pp. 1971-1978
2007 ◽
Vol 9
(9)
◽
pp. 667-676
◽
Keyword(s):
Keyword(s):
2006 ◽
Vol 28
(2)
◽
pp. 266-279
◽
2013 ◽
Vol 190
(3)
◽
pp. 965-972
◽
Keyword(s):